Your browser doesn't support javascript.
loading
QT Interval Prolongation in the Pediatric Oncologic Population on Methadone.
Piccininni, Jenna A; Killinger, James S; Hammad, Hoda T; Gerber, Linda M; Dayton, Jeffrey D.
Afiliação
  • Piccininni JA; Division of Pediatric Cardiology, NewYork Presbyterian/Columbia University Medical Center, Morgan Stanley Children's Hospital of New York.
  • Killinger JS; Departments of Pediatrics.
  • Hammad HT; Divisions of Pediatric Critical Care.
  • Gerber LM; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Dayton JD; Healthcare Policy and Research, Division of Biostatistics and Epidemiology.
J Pediatr Hematol Oncol ; 42(2): e121-e124, 2020 03.
Article em En | MEDLINE | ID: mdl-30830033
ABSTRACT
Studies have been conducted on adults prescribed with methadone to determine the necessary frequency of QTc monitoring but no consensus has been reached and no similar research has been conducted in the pediatric population. The objective of this retrospective study was to determine the occurrence rate of QTc interval prolongation associated with methadone use in a pediatric oncologic population. In total, 18% of patients developed QTc interval prolongation. These patients had longer baseline QTc intervals and were on more QTc interval-prolonging medications. Our data suggest that these variables may be able to risk stratify patients who require more frequent monitoring.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome do QT Longo / Dor do Câncer / Analgésicos Opioides / Metadona / Neoplasias Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome do QT Longo / Dor do Câncer / Analgésicos Opioides / Metadona / Neoplasias Idioma: En Ano de publicação: 2020 Tipo de documento: Article